
AstraZeneca to acquire blood cancer biotech TeneoTwo for $1.27 billion
The transaction will see the British pharma giant AstraZeneca diversify its hematology pipeline. On Tuesday, the British pharmaceutical...
AstraZeneca to acquire blood cancer biotech TeneoTwo for $1.27 billion
U.S. steps up fight against monkeypox, allocates more vaccines
US COVID-19 vaccine starts rollout for young children
WHO warns of “sustained transmission” of monkeypox in vulnerable groups
COVID-19 shot from Sinovac authorized for use in South Africa